Mengyue Li is currently a VP in the IBD Healthcare Team at 中金公司, a position held since 2022. Previously, they served as a Senior Associate in IBD at 中金公司 from 2020 to 2021 and held the role of Associate Director in M&A at 瑞银集团 from 2017 to 2020. Mengyue began their career as an IBD Analyst at CITIC Securities Company Limited from 2016 to 2017. They hold a Master's degree in Finance from 清华大学 and dual Bachelor's degrees in Economics and Pharmaceutical Sciences from 北京大学.
Location
Haidian District, China
This person is not in the org chart
This person is not in any teams
This person is not in any offices